Formulation, Development, and In Vitro Evaluation of a CD22 Targeted Liposomal System Containing a Non-Cardiotoxic Anthracycline for B Cell Malignancies

• Asıl Yazarlar: Nivesh K. Mittal (Yazar), Bivash Mandal (Yazar), Pavan Balabathula (Yazar), Saini Setua (Yazar), Dileep R. Janagam (Yazar), Leonard Lothstein (Yazar), Laura A. Thoma (Yazar), George C. Wood (Yazar)
• Materyal Türü: Kitap
• Baskı/Yayın Bilgisi: MDPI AG, 2018-04-01T00:00:00Z.
• Konular: article
• Online Erişim: Connect to this object online.

Doxorubicin cardiotoxicity has led to the development of superior chemotherapeutic agents such as AD 198. However, depletion of healthy neutrophils and thrombocytes from AD 198 therapy must be limited. This can be done by the development of a targeted drug delivery system that delivers AD 198 to the...